Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CEFTAZIDIME vs CELECOXIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CEFTAZIDIME vs CELECOXIB: Safety Overview

Metric CEFTAZIDIME CELECOXIB
Total FAERS Reports 3,158 31,698
Deaths Reported 696 4,470
Death Rate 22.0% 14.1%
Hospitalizations 1,503 9,081
Average Patient Age 52.0 yrs 56.6 yrs
% Female Patients 43.3% 79.6%
FDA Approval Date Apr 28, 1989 Apr 10, 2023
Manufacturer Hospira, Inc. AiPing Pharmaceutical, Inc.
Route INTRAVENOUS ORAL
Marketing Status Discontinued Prescription